We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Napo announced today the appointment of Darlene Horton, M.D., a biopharmaceutical veteran and leading clinical development expert, to the role of Chief Medical Officer (CMO) for Napo.
RedHill Biopharma Ltd., a speciality company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal (GI) diseases...